Articles tagged with Viruses
A new study by Texas A&M University researchers uses a non-toxic virus to induce Parkinson's-like brain damage and movement problems in animal models. The breakthrough model confirms that viral infections can trigger Parkinson's disease, paving the way for future studies on early warning signs and biological markers.
JMIR Publications invites submissions on the 2026 Ebola disease public health emergency of international concern, focusing on response strategies, risk communication, and surveillance. The World Health Organization has declared a public health emergency due to population mobility and ongoing uncertainty in the Democratic Republic of th...
Researchers have developed a dual-targeting strategy to combat emerging infectious diseases. A fully human monoclonal antibody cocktail provides complete protection against lethal Nipah virus infection, even when treatment is given after infection has begun.
Researchers at Texas A&M University develop a laser technique called TRIP to directly measure quantum forces shaping proteins, enabling accurate prediction of how pharmaceutical drugs interact with them. This breakthrough could lead to the design of medicines tailored to specific diseases, revolutionizing precision medicine.
A University of Minnesota Medical School research team led by Dr. Mark Schleiss has received a $3.87 million NIH grant to investigate congenital CMV transmission during pregnancy. The study aims to develop preventive and therapeutic strategies to improve pregnancy outcomes and prevent lifelong disabilities in children.
Hantavirus and Ebola virus disease are two deadly infectious diseases that require rigorous infection and prevention control (IPAC) practices. Both diseases present with similar early symptoms and can be treated effectively with proper precautions.
A recent study reveals that mosquitoes harbor viruses without killing them due to translational repression, allowing for efficient transmission. The virus takes a moderate approach in mosquito cells, limiting protein production to avoid overloading the host cell.
A study by Okayama University researchers revealed that SARS-CoV-2 antibody levels can assess infection history, symptom severity, and cognitive complications in long COVID. The findings suggest that declining S-antibody levels may indicate a greater risk of neurological complications.
A study led by Dr. Toni Gabaldón rewrites the origin of the first eukaryotes, suggesting a gradual and collaborative process involving multiple bacterial groups and giant viruses. The research provides new insights into the emergence of complex cells in animals, plants, fungi, and protists.
According to new research, a warming climate is making parts of California more suitable for dengue fever transmission. Nearly half of the state's population now lives in areas where conditions allow for local transmission. As temperatures rise, so does the risk of illness and potential outbreaks.
A universal Sarbeco coronavirus vaccine has shown safety and no significant side effects in a human clinical trial, providing protection against multiple viruses, including SARS-CoV-2. The vaccine uses an AI-designed super-antigen to offer lasting protection against emerging virus threats.
International experts will gather in Valencia to discuss phage therapy's translation from isolated successes to widespread clinical implementation. The challenge now is addressing regulation, manufacturing, accessibility, and clinical integration to make phage therapy a routine healthcare solution.
A new predictive model developed at Washington State University can identify the reservoirs of emerging zoonotic viruses and dangerous pathogens like Ebola. The model uses serological data and seasonal biological patterns to narrow down when viruses are most likely to be found in wildlife.
A University of Mississippi-led study reveals counties in the US Deep South with high HIV rates and limited access to prevention tools. Public health leaders can use a prevention gap index to identify areas for targeted intervention and allocate resources effectively.
Researchers developed a miniaturized human intestine model to study EV-A71 infection, revealing the virus's ability to evade the immune system and persist for extended periods. The model showed long-term viral replication without triggering a strong immune response.
The center will develop new phage-based treatments for antibiotic-resistant bacterial infections, predicting which phage to use for which patient and designing more effective phages. The goal is to generate unprecedented data and train AI models to identify the right phage for any patient's infection.
Climate change is likely to spread chikungunya virus into temperate regions like northeastern North America, central Europe, and East Asia, with the Asian tiger mosquito playing a key role in transmission. Public health officials should prepare by tracking mosquitoes, training doctors, and strengthening control measures by 2040.
A Tulane University study found that long-term antiretroviral treatments did not fully restore key immune functions to protect and repair the gut lining in nonhuman primates with SIV. The researchers discovered that diet-derived compounds from vegetables like broccoli and cabbage may support immune activity involved in gut repair.
A recent study by WSU researchers reveals nearly 30% of rodents in the Palouse region showed evidence of past infection with Sin Nombre virus, a deadly respiratory disease. The study also produced the first full genome sequences of SNV strains from the Northwest, highlighting high genetic diversity and viral reassortment.
Researchers at La Jolla Institute for Immunology have discovered that combining key vaccine ingredients could give the body the tools it needs to fight the entire family of arenaviruses with a single vaccine. This approach may protect against life-threatening infections from Lassa virus, Junin virus, and many other arenaviruses.
Researchers at Ohio State University have discovered that dust can be used to track viral outbreaks in indoor settings. The team identified 54 distinct viruses, including SARS-CoV-2 and influenza, using a novel sequencing technique. This method has the potential to provide quick and high-resolution insights into what is happening withi...
The study found substantial state-level variation in HPV vaccine uptake, with Northeastern states exhibiting higher rates and Southern states showing lower rates. Several sociodemographic factors were not significant predictors of vaccination rates, highlighting the need for targeted interventions to improve vaccine uptake.
A new CRISPR protein, Cas12a2, has shown potential for killing sick cells while leaving healthy ones untouched. Researchers have tested its effectiveness in destroying cancer cells and virus-infected cells with promising results.
Research led by University of Utah biologists shows that host genetics and sex influence how influenza viruses evolve. Female mice from a specific strain exhibit accelerated virulence gains compared to male mice.
Researchers at Wake Forest Institute for Regenerative Medicine have identified a unique gene pattern specific to Ebola, allowing doctors to distinguish it from other infections. This discovery has the potential to improve diagnostic tests and save lives in outbreak settings.
Researchers developed an AI-powered methodology to identify and count target viruses more efficiently than previous techniques. The new approach uses electrochemical impedance spectroscopy and machine learning to separate signals from noise, enabling quick and accurate readings across a wide range of titers.
Researchers identify a new coronavirus, CcCoV-KY43, that can enter human cells through the CEACAM6 receptor. The study used genetic sequences and synthesized spike proteins to screen for binding to human receptors, revealing the versatility of alphacoronaviruses in entering human cells.
A new analysis found that prescriptions for curable hepatitis C drugs have declined sharply in recent years, leaving millions without treatment. The researchers urge swift actions to deliver the drugs to those who need them, including increased screening and system-level changes.
Researchers developed a thin plastic film with ultra-fine structures that tear apart viruses on contact, killing them through mechanical force. The film offers a scalable and practical alternative to existing antiviral coatings.
Keratinocytes play a more active role in rabies infection than previously thought, supporting viral replication and transmitting the virus to neurons. This discovery provides new insights into the risk of infection from superficial scratches or minor bites.
Researchers have found that COVID vaccines can train immune cells to remember the SARS-CoV-2 virus and protect against severe infection for years afterward. However, the continued spread of disease has scientists taking a closer look at how the immune system builds up immune memory over time.
Researchers at Kyoto University have detailed the structure of Borna disease virus 1's nucleoprotein-RNA complex, revealing a distinct binding mode and incremental model of viral replication. The study provides a molecular framework for targeting viral RNA synthesis and assembly.
A new study by University of Maryland researcher Meredith Gore and colleagues found that traded wild mammals are 1.5 times more likely to share infectious agents with humans than species not involved in trade. The risk is higher for animals traded illegally or sold live, which fuels the demand for exotic pets.
Researchers found that microorganisms in the plastisphere have more functional genes to survive under extreme ocean conditions. They can absorb nutrients effectively and utilize alternative energy sources like anoxygenic photosynthesis.
A new NIH-funded study predicts that HIV infections could increase by an average of 10% in 18 US states if CDC funding for HIV testing ends. The simulation model examined HIV infections across different populations and found that the number of infections varies widely across states.
Researchers at University of Michigan have developed a fast method to measure the effectiveness of plasma-based air disinfection, which can deactivate up to 99.9% of virus particles. The approach harnesses UV fluorescence to track changes in aerosol infectivity in real-time, providing essential information for public health guidelines.
Research reveals that viruses can eavesdrop on each other using chemical signals, which may not always benefit the listener. This 'cross-talk' between species can lead to incorrect decision-making by the eavesdropper.
A study of viral abundance in the Sargasso Sea reveals that viruses with cyclical changes in abundance are most active at night, infecting heterotrophic host microbes. This finding opens new questions about the ecological services provided by oceans and highlights the importance of including viruses in ocean models.
A $2M USDA grant funds research on bird flu's infectivity in the air, with goals of preventing or mitigating future outbreaks. Nonthermal plasma technology has been shown to deactivate airborne virus particles.
Researchers at Linköping University found that an existing medication can restore immune cell function in people with HIV. The study showed that the medication blocks type I interferon and restored the function of immune cells, potentially improving health outcomes.
Researchers discovered Marburg virus enters human cells up to 300 times more efficiently than Ebola, thanks to its unique entry protein. A nanobody has been identified to block its attachment to the receptor, providing a potential therapeutic strategy.
A new international study reveals that the ancestors of modern crop viruses likely emerged before the last Ice Age, affecting both wild and cultivated plants. The viruses, spread by leaf-eating beetles, infect various crops and wild species, posing risks to agriculture and natural ecosystems.
Researchers at Duke-NUS Medical School found that testing air and surfaces can detect a broader range of poultry viruses, including highly pathogenic avian influenza strains, which traditional surveillance may miss. Environmental sampling can provide a more comprehensive view of viral circulation in live poultry markets.
Researchers from the University of Southern Denmark have identified a new virus in a common gut bacterium that appears more frequently in patients with colorectal cancer. The study demonstrates a statistical association between the virus and colorectal cancer, but its role is still unclear.
A new review highlights the potential of viral mimic systems and virus-like particle technologies to accelerate vaccine development and improve global health equity. These innovative approaches enable local testing of vaccine candidates and antiviral therapies, strengthening regional preparedness for future outbreaks.
A recent study found that chikungunya can spread in temperatures as low as 13 degrees Celsius, posing a greater health threat in Europe than previously thought. The Asian tiger mosquito is expanding northwards through the continent, and warming temperatures may lead to local outbreaks in the UK.
Researchers at Ragon Institute discovered that antibodies produced in germinal centers act as a 'brake' on selection, redirecting the immune system toward broader protection. Stronger-binding B cells suppress weaker ones targeting the same site, establishing a localized feedback loop.
A new study found that tuberculosis is a major cause of deadly sepsis among people living with HIV, particularly in Africa. Early treatment of TB has been shown to significantly reduce sepsis deaths, with a 23% reduction in mortality rate.
Researchers developed a DNA scaffold that ignores the immune system, eliminating off-target antibodies and promoting focused immune responses. The DNA-based vaccines led to 10 times more immune cells targeting vulnerable sites on HIV, outperforming protein-scaffolded vaccines.
A new experimental intranasal spray, INNA-051, will be tested in a randomized Phase 2 trial to determine its safety and effectiveness in reducing illness from respiratory viruses. The study aims to enroll 1,100 healthy adults at increased risk of upper respiratory virus infections.
Researchers identify thousands of rapidly evolving receptor-binding proteins, revealing how bacteria can be engineered to deliver proteins into specific human cells. The study provides insights into the evolutionary creativity of bacterial machines and their potential biomedical applications.
The new platform developed by UVA Health scientists can produce vaccines much faster, cheaper, and more easily than traditional approaches. The platform's proof-of-concept demonstrates its ability to produce highly immunogenic vaccines that can be manufactured at extremely low cost.
The CDC recommends RSV vaccination for pregnant women to protect their newborns, while a monoclonal antibody injection is also available for high-risk infants. Most experts agree that RSV immunizations should be recommended for these groups due to the severity of the illness they can cause.
Researchers analyzed faecal samples from 82 captive and 16 wild marsupials, revealing new microbial species and antimicrobial resistance. The study found that host family, location, and diet contributed to variance between different microbiomes.
A new foot-and-mouth disease vaccine developed by Diamond Light Source is projected to deliver over $1.3 billion in annual benefits, transforming global livestock resilience. The vaccine's unique features, including heat stability and scalability, make it a game-changer for farmers worldwide.